Argenx
ARGX
#539
Rank
โ‚น3.203 T
Marketcap
โ‚น52,460
Share price
0.23%
Change (1 day)
67.60%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): โ‚น7.34 Billion

According to Argenx 's latest financial reports the company's current earnings are โ‚น2.19 Billion. , an increase over its 2023 earnings that were of -โ‚น25.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น7.25 B-127.97%
2023 -โ‚น25.93 Billion-58.25%
2022 -โ‚น62.1 Billion
2019 -โ‚น16.95 Billion124.95%
2018 -โ‚น7.54 Billion132.04%
2017 -โ‚น3.25 Billion54.86%
2016 -โ‚น2.1 Billion33%
2015 -โ‚น1.58 Billion13.63%
2014 -โ‚น1.39 Billion46.25%
2013 -โ‚น0.95 Billion